3TH9
Crystal Structure of HIV-1 Protease Mutant Q7K V32I L63I with a cyclic sulfonamide inhibitor
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | A, B | Gag-Pol polyprotein | polymer | 99 | 10804.8 | 2 | UniProt (P0C6F2) Pfam (PF00077) In PDB | Human immunodeficiency virus type 1 lw12.3 isolate (HIV-1) | Protease |
2 | A, B | tert-butyl {(2S,3R)-4-[(4S)-7-fluoro-4-methyl-1,1-dioxido-4,5-dihydro-1,2-benzothiazepin-2(3H)-yl]-3-hydroxy-1-phenylbutan-2-yl}carbamate | non-polymer | 492.6 | 2 | Chemie (9Y9) | |||
3 | water | water | 18.0 | 238 | Chemie (HOH) |
Sequence modifications
A, B: 1 - 99 (UniProt: P0C6F2)
PDB | External Database | Details |
---|---|---|
Lys 7 | Gln 495 | engineered mutation |
Ile 33 | Leu 521 | engineered mutation |
Ile 63 | Leu 551 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 2 |
Total formula weight | 21609.6 | |
Non-Polymers* | Number of molecules | 2 |
Total formula weight | 985.2 | |
All* | Total formula weight | 22594.8 |